• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Agilent’s profits leap 800 percent

Agilent’s profits leap 800 percent

November 13, 2010 By MassDevice staff

A logo

Agilent Technologies Inc. (NYSE:A) reported that its 2010 fourth-quarter profit soared more than 800 percent, as orders jumped in all sectors and its acquisition of Varian Inc. began to pay off.

The Santa Clara, Calif.-based electronic testing equipment maker reported profits of $232 million, or 66 cents per diluted share, on sales of $1.58 billion for the three months ended Oct. 31. That compares with profits of $25 million, or 7 cents per diluted share, on sales of $1.17 billion a year earlier. The number includes a $42 million tax benefit and a $54 million gain related to the closure of pre-Agilent spin-off income tax audits.

The company, which develops devices to analyze chemicals and DNA, said its orders jumped 32 percent to $1.69 billion for its Q4.

Revenue from its chemical analysis business grew 73 percent to $389 million, while revenue from its life science business rose 35 percent to $431 million. The two segments together accounted for nearly half of the company’s total revenue for the fourth quarter. Electronic Measurement revenues were up 23 percent from a year earlier

The company said its integration of Varian is on track to meet targeted revenue after the $1.5 billion acquisition completed in May.

“This past quarter marked the completion of Agilent’s transformation, a milestone in our company’s history,” said Agilent CEO Bill Sullivan in prepared remarks.

The fourth-quarter results include a tax benefit of $42 million and a $54 million gain from the closure of pre-Agilent spin-off income tax audits. It has Varian-related integration costs of $43 million, intangible amortization of $30 million and restructuring charges of $18 million.

For the current quarter, Agilent expects revenue to be between $1.53 billion and $1.55 billion, and adjusted earnings to be between $0.55 per share and $0.57 per share.

“We are starting the new fiscal year with an industry-leading product portfolio and expect to continue the momentum with strong organic growth and great market opportunities created by the Varian product portfolio,” said Sullivan.

Agilent shares closed at $36.36, up about 1.8 percent for the day.

Filed Under: Business/Financial News, MassDevice Earnings Roundup, News Well Tagged With: Agilent Technologies Inc.

More recent news

  • Vicarious Surgical inks surgical robot collab with hospital, eyes first clinical patients
  • Bioliberty launches hub for soft-robotic wearable devices
  • Zynex submits laser pulse oximeter to FDA
  • Roche invests $550M to make Indianapolis a CGM manufacturing hub
  • Product liability lawsuits target Medtronic, Boston Scientific spinal cord stim tech

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy